Insights

Innovative Cell Analysis BennuBio develops advanced cell analysis systems capable of handling large multicellular spheroids and single cells with high throughput, offering potential for laboratories seeking rapid, detailed cellular data for research and diagnostics.

Recognition & Awards The company's receipt of the SLAS Ignite Award in 2022 highlights its innovative technology and industry credibility, making it an attractive partner for research institutions and biotech firms interested in cutting-edge automation solutions.

Strategic Acquisition The recent acquisition by Precision Cell Systems positions BennuBio within a larger portfolio focused on 3D cell culture, presenting opportunities to collaborate or sell to a broader customer base involved in immuno-oncology and physiopathology research.

Funding & Growth With over $6 million invested during its development phase and recent high-tech facility expansion, BennuBio demonstrates strong growth potential and a commitment to commercializing its innovative cell screening technology, ideal for sales targeting early adopters in biotech.

Market Focus BennuBio's technologies target high-precision diagnostics and therapeutics development, presenting sales opportunities with biopharma and diagnostic labs seeking next-generation tools for disease characterization and personalized medicine advancements.

Similar companies to BennuBio, Inc.

BennuBio, Inc. Tech Stack

BennuBio, Inc. uses 8 technology products and services including RSS, oEmbed, Lodash, and more. Explore BennuBio, Inc.'s tech stack below.

  • RSS
    Content Management System
  • oEmbed
    Dev Tools
  • Lodash
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • X-XSS-Protection
    Security
  • Bootstrap
    UI Frameworks
  • Animate.css
    UI Frameworks
  • Google Analytics
    Web Analytics

Media & News

BennuBio, Inc.'s Email Address Formats

BennuBio, Inc. uses at least 1 format(s):
BennuBio, Inc. Email FormatsExamplePercentage
First.Last@bennubio.comJohn.Doe@bennubio.com
45%
Last@bennubio.comDoe@bennubio.com
8%
First@bennubio.comJohn@bennubio.com
2%
First.Last@bennubio.comJohn.Doe@bennubio.com
45%

Frequently Asked Questions

Where is BennuBio, Inc.'s headquarters located?

Minus sign iconPlus sign icon
BennuBio, Inc.'s main headquarters is located at 6610 Gulton Court Northeast Albuquerque, New Mexico 87109 United States. The company has employees across 2 continents, including North AmericaSouth America.

What is BennuBio, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
BennuBio, Inc.'s official website is bennubio.com and has social profiles on LinkedInCrunchbase.

What is BennuBio, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
BennuBio, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BennuBio, Inc. have currently?

Minus sign iconPlus sign icon
As of April 2026, BennuBio, Inc. has approximately 7 employees across 2 continents, including North AmericaSouth America. Key team members include Chief Science Officer: J. F.Chief Financial Officer & Advisor: S. M.Founder & Director Of Technology: S. G.. Explore BennuBio, Inc.'s employee directory with LeadIQ.

What industry does BennuBio, Inc. belong to?

Minus sign iconPlus sign icon
BennuBio, Inc. operates in the Biotechnology Research industry.

What technology does BennuBio, Inc. use?

Minus sign iconPlus sign icon
BennuBio, Inc.'s tech stack includes RSSoEmbedLodashYoast SEOX-XSS-ProtectionBootstrapAnimate.cssGoogle Analytics.

What is BennuBio, Inc.'s email format?

Minus sign iconPlus sign icon
BennuBio, Inc.'s email format typically follows the pattern of First.Last@bennubio.com. Find more BennuBio, Inc. email formats with LeadIQ.

When was BennuBio, Inc. founded?

Minus sign iconPlus sign icon
BennuBio, Inc. was founded in 2018.

BennuBio, Inc.

Biotechnology ResearchNew Mexico, United States2-10 Employees

We are an emerging technology company delivering unique cell analysis systems accommodating large multi-cellular spheroids and single cell analyses at 10 – 100x flow volume and event rates.  The VelocytTM enables near total analyzed sample recovery for further re-analysis, dynamic cellular kinetic studies or repurpose to other workflows.  We are also creating viable cell preserving, rapid enrichment technologies to purify specific cells for in vitro expansion to enable advanced immuno-oncology treatment or selectively isolate and further characterize specific circulating cells and disease states to develop higher precision diagnostics, guidance therapeutics and prediction of minimum residual disease. (The Velocyt is presently not approved by US FDA for in vitro diagnostic purposes)

Section iconCompany Overview

Headquarters
6610 Gulton Court Northeast Albuquerque, New Mexico 87109 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
2-10

Section iconFunding & Financials

  • $1M$10M

    BennuBio, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    BennuBio, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.